Skip to main content

Advertisement

Table 1 Patient characteristics at baseline

From: The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis

Parameter Value
n 10
Sex (male : female) 7:3
Age (years old) 62.9±4.3
Duration of diabetes (years) 25.4 ± 2.3
Duration of HD (years) 4.1±1.1
BMI (kg/m2) 23.0±1.5
Dose of insulin (U/day) 11.6±1.9
Glycated albumin (%) * 24.1 ± 1.5
S-CPR (ng/ml) 6.7 ± 1.3
spKTV 1.44 ± 0.09
Cre (mg/dl) 9.72±0.91
PTH (pg/ml) 88.0 ± 31.4
AST (U/l) 9.3 ± 1.1
ALT (U/l) 9.7 ± 1.3
gGTP (U/l) 16.9 ± 2.2
Total choresterol (mg/dl) 162.1 ± 8.1
Triglyceride (mg/dl) 120.1 ± 20.6
Blood glucose (mg/dl) 162.1 ± 8.1
Complications  
Macroangiopathy (− / +) (6/4)
Neuropathy (− / +) (0/10)
Retinopathy (− / +) (0/10)
  1. Values are means ± SEM or n. *n=9.